Nike reports fiscal Q1 2027 earnings on 1 October. We preview China performance, gross margin trends, wholesale versus Direct and the outlook for the turnaround.

Micron reports fiscal Q4 earnings on 30 September with revenue guidance of $50bn. We preview HBM demand, gross margin trends, FY2027 guidance and what to watch.

Brent crude climbed above $107 a barrel for a second consecutive session as concerns over Middle East supply disruptions linked to the US-Iran war outweighed signs of recovering Gulf exports. Dollar ...

Technical analysis of the FTSE 10, GBP/USD as they range trade above support while the gold price drops like a stone.

AstraZeneca shares hit a two-month high after a $2bn Summit Therapeutics deal. We look at what ivonescimab means for AstraZeneca's oncology pipeline and the shares.

Tesco reports H1 2026/27 interim results on 8 October. We preview UK sales momentum, market share trends, Booker weakness and the £3bn-£3.3bn profit guidance.

J D Wetherspoon reports full-year results on 2 October after a profit warning in July. We preview the margin squeeze, cost outlook and what investors should watch ...

No rockets or rumours needed. Discover why boring, dependable businesses like Coca-Cola, Amex and Chubb are core to Buffett's approach.

Après un repli proche de 10%, le CAC 40 tente de préserver les 8 000 points, mais le pétrole, les taux et le risque politique restent déterminants.

Nike hat 2026 rund 44 % verloren. Vor den Zahlen am 1. Oktober zählen die 35-Dollar-Marke, die Saisonalität und eine erwartete Bewegung von 8,6 %.

Anthropic strebt beim IPO über zwei Billionen Dollar Bewertung an. Umsatz, Verluste und KI-Risiken im Überblick – plus Pre-IPO-Handel bei IG.

Micron legt am 30. September Zahlen vor. Analysten sehen rund 39 % Potenzial. Entscheidend sind der Pullback und das Chartziel bei 1.225 Dollar.